Incidence of COVID-19 after vaccination. Analysis of publicly available data

• Main Authors: V. Divocha, W. Zukow, A. Gozhenko
• Format: Article
• Language: English
• Published: Kazimierz Wielki University 2021-07-01
• Series: Journal of Education, Health and Sport
• Subjects: coronaviruses; vaccines; number of vaccinated; coronavirus deaths; complications after vaccination.
• Online Access: https://apcz.umk.pl/czasopisma/index.php/JEHS/article/view/34813
• ISSN: 2391-8306

<p class="MsoNormal" style="text-indent: 35,4000pt; text-align: justify; text-justify: inter-ideograph;" align="justify"><span style="mso-spacerun: 'yes'; font-family: 'Times New Roman'; font-size: 12,0000pt; mso-font-kerning: 0,0000pt;">The coronavirus began in late 2019 in China's Hubei province. Since then, it has spread around the world. In the world, according to official data, more than 100 million people have become infected, more than 3 million have died from the coronavirus.</span></p><p class="MsoNormal" style="text-indent: 35,4000pt; text-align: justify; text-justify: inter-ideograph;" align="justify"><span style="mso-spacerun: 'yes'; font-family: 'Times New Roman'; font-size: 12,0000pt; mso-font-kerning: 0,0000pt;">On 18.03.2020, the first coronavirus vaccine trials began. Currently, 5 vaccines are used for vaccination: Pfizer, Moderna, AstraZeneca, Johnson and Johnson and Sputnik-V. No vaccine against COVID-19 protects a person 100% from the incidence of coronavirus. Average mortality rate as of 19.04.2021. 1. Pfizer-39,4; 2. Moderna-20,2; 3. AstraZeneca-12,8; 4. Johnson and Johnson-7,5; 5. Sputnik V-2,0. Pfizer and Moderna vaccines cause a risk of cardiovascular disease (myocarditis and pericarditis), thrombosis, bleeding and embolism.</span></p>